Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.68 – $0.82
100% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $23.49B | $25.67B | $23.85B | $26.89B | $20.75B | $22.89B | $25.52B | $1.44B |
| Cost of revenue | $6.88B | $7.53B | $7.73B | $8.54B | $14.88B | $16.41B | $7.71B | $1.11B |
| Gross profit | $16.61B | $18.15B | $7.36B | $18.35B | $5.87B | $6.48B | $17.81B | $336.2M |
| Gross margin | 70.7% | 70.7% | 30.9% | 68.2% | 28.3% | 28.3% | 69.8% | 23.3% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $3.85B | $3.94B | $2.12B | $3.01B | $2.76B | $2.44B | $2.90B | $126.6M |
| EBITDA | $5.24B | $6.28B | $4.16B | $4.42B | $3.30B | $3.37B | $4.42B | $59.1M |
| Net income | $1.57B | $2.57B | −$93.0M | $1.75B | $1.53B | $264.0M | $4.83B | $222.2M |
| Net margin | 6.7% | 10.0% | -0.4% | 6.5% | 7.4% | 1.2% | 18.9% | 15.4% |
| EPS (diluted) | 1.08 | 1.76 | -0.06 | 1.14 | 1.05 | 0.18 | 3.26 | 0.15 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $1.6B | $0.07 | $0.07–$0.07 | 1 |
| 2027 | $1.6B | $0.07 | $0.07–$0.08 | 1 |
| 2028 | $1.7B | $0.08 | $0.08–$0.08 | 1 |
Forward consensus · source: Financial Modeling Prep
LIFE HEALTHCARE GRP HLDGS
No one on the platform currently holds LTGHF.
No tracked institution reports a position in LTGHF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-06-18 | $0.2300 | 2026-06-22 |
| 2025-12-19 | $0.3500 | 2025-12-22 |
| 2025-09-19 | $2.3500 | 2025-09-22 |
| 2025-06-13 | $0.2100 | 2025-06-17 |
| 2025-01-10 | $0.7000 | 2025-01-13 |
| 2024-12-13 | $0.3100 | 2024-12-17 |
| 2024-06-14 | $0.1900 | 2024-06-18 |
| 2024-04-04 | $6.0000 | 2024-04-08 |
| 2023-12-13 | $0.2700 | 2023-12-18 |
| Execution date |
|---|
No one on the platform has traded LTGHF yet.
| +0.00% |
| $185M |
| — |
| RAFLFRaffles Medical Group Ltd | $0.75 | +0.00% | $1.4B | — |
| RHKJFRhoen-Klinikum AG | $15.30 | +0.00% | $1.0B | — |
Source: Financial Modeling Prep · peers by sector/industry
| Ratio |
|---|
| 2018-06-21 | 1.0141843-for-1 |
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.